Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

4th approved indication for toripalimab

SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New Drug Application (sNDA) for toripalimab …

Read More

Isolated rain showers to prevail across PH

MANILA – Isolated rain showers caused by localized thunderstorms will prevail over most parts of the archipelago, the weather bureau said Tuesday.

In its 4 a.m. weather bulletin, the Philippine Atmospheric, Geophysical and Astronomical Services Administration (PAGASA) said shear line would bring scattered rain showers …

Read More

LGUs can order mandatory vaccination: DILG

MANILA – Local government units (LGUs) have the authority to impose mandatory inoculation against Covid-19 and eliminate hesitancy and brand preference.

Department of the Interior and Local Government (DILG) Secretary Eduardo Año said local chief executives have autonomous power based on Section 16 of the …

Read More

Weak explosion recorded in Mt. Pinatubo

MANILA – Weak explosion at Mount Pinatubo was recorded between 12:09 p.m. to 12:13 p.m., the Philippine Institute of Volcanology and Seismology (Phivolcs) reported Tuesday afternoon.

This generated a plume that was detected by Japan’s Himawari-8 Satellite.

“The seismic and infrasound signals are not typical …

Read More

EJ Obiena stays loyal to PH

MANILA – Ernest John “EJ” Obiena has assured that he will continue to represent the Philippines despite offers to switch allegiances.

The world number six pole vaulter confirmed late Monday night that there have been lucrative deals for him to consider naturalization, but maintained that …

Read More

Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, Omicron, Are Associated with Escape from ADG20 Neutralization In Vitro

Additional in vitro studies to determine neutralization activity of ADG20 against Omicron are ongoing

ADG20 EUA submissions planned for prevention and treatment of COVID-19 in mid-2022

Inventory build continues in anticipation of EUA in second half of 2022, with 4 million doses available for distribution

Read More